NUZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neurizon Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.085 AUD -4.49% Market Closed

Market Cap: AU$65.9m

	Neurizon Therapeutics Ltd ASX:NUZ	AU
B	Broadcom Inc XMUN:1YD	US
	Arbonia AG SIX:ARBN	CH
	Tsentral'nyi Telegraf PAO MOEX:CNTL	RU
N	Nebius Group NV F:YDX	NL
I	Indo Pureco Pratama Tbk PT IDX:IPPE	ID
K	Kalbe Farma Tbk PT XMUN:LCLA	ID
	Vestas Wind Systems A/S CSE:VWS	DK
C	Cirtek Holdings Philippines Corp XPHS:TECH	PH
V	Vienna Insurance Group Wiener Versicherung Gruppe AG F:WSV2	AT
E	Euroapi SAS PAR:EAPI	FR
C	CVS Health Corp XMUN:CVS	US
	Empire Petroleum Corp F:6W8	US

Profitability Summary

Neurizon Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1,234%

Negative 3Y Average Operating Margin

-780%

Negative Net Margin

-423%

Negative 3Y Average Net Margin

-624%

Negative Free Cash Flow Margin

-1,231%

Negative 3Y Average Free Cash Flow Margin

-617%

Negative ROE

-67%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

831%

Declining ROIC

-36% > -506%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.